210 related articles for article (PubMed ID: 23555960)
1. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
2. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
3. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.
Castejón R; Vargas JA; Romero Y; Briz M; Muñoz RM; Durántez A
Cytometry; 1999 Oct; 38(5):224-30. PubMed ID: 10516608
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
5. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
6. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
Dancescu M; Rubio-Trujillo M; Biron G; Bron D; Delespesse G; Sarfati M
J Exp Med; 1992 Nov; 176(5):1319-26. PubMed ID: 1402678
[TBL] [Abstract][Full Text] [Related]
10. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis.
Gamberale R; Geffner J; Arrosagaray G; Scolnik M; Salamone G; Trevani A; Vermeulen M; Giordano M
Leukemia; 2001 Dec; 15(12):1860-7. PubMed ID: 11753606
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
12. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.
Barragán M; Bellosillo B; Campàs C; Colomer D; Pons G; Gil J
Blood; 2002 Apr; 99(8):2969-76. PubMed ID: 11929788
[TBL] [Abstract][Full Text] [Related]
13. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
15. The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia.
Bomstein Y; Yuklea M; Radnay J; Shapiro H; Afanasyev F; Yarkoni S; Lishner M
Eur J Haematol; 2003 May; 70(5):290-5. PubMed ID: 12694164
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
18. Differential effects on CLL cell survival exerted by different microenvironmental elements.
Ghia P; Circosta P; Scielzo C; Vallario A; Camporeale A; Granziero L; Caligaris-Cappio F
Curr Top Microbiol Immunol; 2005; 294():135-45. PubMed ID: 16323430
[TBL] [Abstract][Full Text] [Related]
19. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
